Cardiovascular Research

Cardiovascular Research 2001 50(1):151-161; doi:10.1016/S0008-6363(01)00202-4
© 2001 by European Society of Cardiology

This Article Abstract FREE Full Text (PDF) E-letters: Submit a response Alert me when this article is cited Alert me when E-letters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to citation manager Request Permissions Disclaimer Google Scholar Articles by Chareonthaitawee, P. Articles by Camici, P. G Search for Related Content PubMed PubMed Citation Articles by Chareonthaitawee, P. Articles by Camici, P. G Social Bookmarking          What's this?

Copyright © 2001, European Society of Cardiology

Heterogeneity of resting and hyperemic myocardial blood flow in healthy humans

Panithaya Chareonthaitawee^a,c, Philipp A Kaufmann^b, Ornella Rimoldi^c and Paolo G Camici^c,*

^aDivision of Cardiovascular Diseases and Internal Medicine, Mayo Clinic and Foundation, Rochester, MN 55905, USA
^bCardiovascular Center, Nuclear Cardiology University Hospital, Zürich, Switzerland
^cMRC Clinical Sciences Centre, Imperial College School of Medicine, Hammersmith Hospital, Du Cane Road, London W12 ONN, UK

^* Corresponding author. Tel.: +44-20-8383-3186; fax: +44-20-8383-3742 paolo.camici{at}csc.mrc.ac.uk

Received 4 October 2000; accepted 18 December 2000

	Abstract

Top Abstract 1 Introduction 2 Methods 3 Results 4 Discussion 5 Conclusions References

 
Objective: Absolute myocardial blood flow (MBF) is not well-defined in large normal populations, and appears to be heterogeneous in both humans and animals. These factors contribute to the difficulties in defining resting MBF to hibernating myocardium. We therefore assessed absolute baseline and hyperemic MBF in a large population of normal humans. Methods: MBF was quantified by positron emission tomography with oxygen-15-labeled water at baseline and during hyperemia induced by either adenosine or dipyridamole in 131 men and 38 women, aged 21–86 (mean 46±12) years. MBF was corrected for workload using the rate-pressure product (RPP). Results: Uncorrected baseline MBF ranged from 0.590 to 2.050 (mean 0.985±0.230) ml/min/g (coefficient of variation=27%), and corrected MBF from 0.736 to 2.428 (mean 1.330±0.316) ml/min/g (coefficient of variation=24%). MBF in the inferior region was significantly (P<0.0001) lower than either the anterior or lateral regions. Baseline MBF in females was significantly (P<0.001) higher than in males. Conclusions: These results confirm the heterogeneity of MBF in normals and highlight the difficulty in establishing the lower limit of normal MBF.

KEYWORDS Adenosine; Blood flow; Coronary circulation

	1 Introduction

Top Abstract 1 Introduction 2 Methods 3 Results 4 Discussion 5 Conclusions References

 
A number of recent studies using positron emission tomography (PET) have demonstrated that resting myocardial blood flow (MBF) to hibernating myocardium is often within normal limits [1–4]. This is in contrast with other reports showing that resting flow to hibernating myocardium is reduced [5]. Part of the problem lies in the fact that resting MBF is heterogeneous in both normal humans and animals [6–14]. As a consequence, it is difficult to define the range and particularly the lower limit of normal resting MBF. In addition, the small sample size of most published reports could contribute, at least in part, to this heterogeneity. Studies of MBF in larger populations might help to overcome this limitation.

Several techniques are available for measuring coronary or myocardial blood flow in humans, including Doppler catheterization, quantitative coronary arteriography, thermodilution, and measurement of inert tracer clearance [15]. However, most methods are invasive and affected by serious limitations [15]. Noninvasive assessment of MBF may be performed with either single photon emission computerized tomography (SPECT) or PET, but the physical limitations of SPECT do not permit absolute quantitation of MBF. On the other hand, PET overcomes some of these limitations by providing superior resolution and accurate attenuation and partial volume corrections, thus enabling reproducible absolute quantification of regional MBF [16,17]. The aim of this study was therefore to measure absolute baseline and hyperemic MBF in a large group of normal volunteers using PET with oxygen-15 labeled water (H₂¹⁵O).

	2 Methods

Top Abstract 1 Introduction 2 Methods 3 Results 4 Discussion 5 Conclusions References

 
2.1 Study population
We have accumulated MBF data in a large group of normal volunteers from a number of different studies. The current retrospective series was produced using this database. The study population consisted of 169 healthy volunteers (38 women and 131 men) aged 21–86 years (mean±S.D., 46±12 years). Volunteers were recruited by public advertising or from hospital staff. Volunteers over the age of 80 years were recruited from a ballroom dancing class. The mean age of females was significantly higher than that of males (54±13 vs. 44±11 years; P<0.0001). All subjects gave no history of cardiac or pulmonary disease, hypertension, hyperlipidemia, diabetes, or smoking. In 76 subjects a lipid profile was also obtained and was within normal limits (mean total cholesterol 4.5±0.4, range 1.9–5.3 mmol/l). All subjects gave history of normal effort tolerance, had a normal cardiac and pulmonary examination, and a normal resting electrocardiogram. Based on these findings, all participants had a low clinical probability of coronary artery disease [18].

2.2 Study protocol
The study protocol was approved by the Research Ethics Committee of Hammersmith Hospital and radiation exposure was licensed by the United Kingdom Administration of Radioactive Substances Advisory Committee (ARSAC). The study conforms with the principles outlined in the Declaration of Helsinki. All participants gave informed and written consent prior to the study.

Subjects were investigated by means of PET for the quantification of MBF (1) at baseline (n = 169) and (2) during hyperemia (n = 160) induced by standard intravenous dipyridamole (0.56 mg/kg infused over 4 min, n = 83) or adenosine (140 µg/kg/min, n = 77). Only dipyridamole was used in females (n = 36), and either dipyridamole (n = 47) or adenosine (n = 77) was used in males. This was because the female volunteers were part of the control group for specific studies in which only dipyridamole was used. In a subgroup of 21 male subjects, repeated measurements of MBF were performed at rest and during adenosine-induced hyperemia. The two baseline studies were timed to be exactly 20 min apart, and the two hyperemic studies were also exactly 20 min apart.

For the measurement of MBF, a slow bolus of H₂¹⁵O was injected 2 min after the beginning of adenosine infusion or 90 s after completion of dipyridamole infusion. The timing of the H₂¹⁵O injection and scan for the dipyridamole hyperemic MBF was based on our previous observation [19] that, on average, peak coronary hyperemic response to dipyridamole occurs 8 min after the start of infusion or, 4 min following the end of the dipyridamole infusion. The H₂¹⁵O infusion was therefore timed so that its peak coincided with the peak action of dipyridamole. Blood pressure was recorded by Dynamap (Critikon, Tampa, FL, USA) at baseline and at 1-min intervals during adenosine or dipyridamole infusion. The heart rate and rhythm were monitored continuously throughout the procedure by a microprocessor-driven electrocardiographic recorder (Sirecust 341, Siemens, Germany). One set of blood pressure and heart rate was recorded to coincide with the peak action of the H₂¹⁵O bolus and pharmacologic stress agent. A 12-lead electrocardiogram (Marquette, Milwaukee, WI, USA) was obtained at baseline and every minute of the adenosine or dipyridamole infusion.

2.3 PET scanning procedure
The PET scans were performed with an Ecat 931-08/12 15-slice tomograph (CTI/Siemens, Knoxville, TN, USA). The scanner enables the acquisition of 15 planes of data over a 10.5-cm axial field of view, allowing the whole heart to be imaged. All emission and transmission data were reconstructed with a Hanning filter with a cut-off frequency of 0.5 units of reciprocal of the sampling interval of the projection data, achieving an image resolution of 8.4x8.3x6.6 mm³ full-width half maximum at the center of the field of view [20].

All subjects were asked to abstain from caffeine-containing beverages for 24 h before the scan. Blood was drawn for caffeine levels, which were nonmeasurable in all subjects tested prior to the study. Subjects were positioned in the scanner, and after exposure of a retractable ⁶⁸Ge ring source, a 5-min rectilinear transmission scan was acquired to determine the optimal imaging position of the left ventricle within the field of view. A 20-min transmission scan was subsequently performed for the purpose of attenuation correction of all emission scans. To maintain the optimal imaging position of the subject within the scanner, a low power laser beam was superimposed on a cross-shaped ink mark on the subject's chest and this position was kept constant throughout all the emission scans. Starting after a 30-s background frame, a bolus of H₂¹⁵O (700–900 MBq) was injected intravenously over 20 s at an infusion rate of 10 ml/min. The venous line was then flushed for another 2 min. The following scanning protocol was used: fourteen frames at 5 s, three frames at 10 s, three frames at 20 s, and four frames at 30 s, for a total scanning time of 310 s. The H₂¹⁵O bolus injection/scan was repeated after adenosine- or dipyridamole-induced hyperemia.

2.4 PET image processing
The acquired sinograms were corrected for attenuation and reconstructed on a Microvax II computer (Digital Equipment, Marlboro, MA, USA) using dedicated array processors and standard reconstruction algorithms. Images were then transferred to a Sun Sparc 2 workstation (Sun Microsystems, Mountainview, CA, USA). Images were analyzed with customized MATLAB software (The Mathworks Natick, MA, USA). Myocardial images were generated directly from the dynamic H₂¹⁵O study. Briefly, regions of interest defined in the lungs on the transmission image provided the required variate and covariate factors (the myocardial and blood time–activity curves) for modeling of factor sinograms by means of the recently reported linear dimension reduction [21,22]. Factor images were generated by iterative reconstruction [23]. Regions of interest were then drawn in the left atrium and right ventricle on four to six consecutive image planes and projected onto the dynamic H₂¹⁵O images to generate blood time–activity curves (arterial and venous input function). Similarly, four myocardial region of interest (septal, anterior, lateral and inferior) were drawn in the left ventricular myocardium on 12 consecutive planes and projected onto the dynamic H₂¹⁵O images to obtain tissue time–activity curves. Arterial, venous and tissue input functions were the fitted to a single tissue compartment tracer kinetic three-parameter model to give values of regional and global MBF (ml/min/g) as previously described [23,24]. When applied to the septum a four-parameter model was used in order to correct for the spillover from the right ventricle.

To account for the changes in MBF produced by cardiac workload, baseline MBF was also corrected for the rate pressure product (RPP), an index of myocardial oxygen consumption, using the formula: MBF_corr=(MBF_baseline/RPP)x10⁴. Coronary vasodilator reserve (CVR) was calculated as the ratio of MBF_ado/dip to MBF_baseline. In addition, CVR was also calculated using baseline MBF corrected for RPP as CVR_corr=MBF_ado/dip/MBF_corr [17].

2.5 Statistical analysis
All values are reported as mean±S.D. Statistical analysis was performed using the Statview package (SAS Institute, Cary, NC, USA). The coefficient of variation was used to demonstrate the degree of variability of MBF and CVR. A standard Wald-type test was used to compare the coefficients of variation between the first and second flow assessments at baseline and during hyperemia [25]. Paired t-tests were used to compare regional MBF within individuals at a single time point. Simple, multiple and polynomial regression were performed to assess the relationships between independent variables (age, gender, hemodynamic variables, stressor) and MBF and CVR. Gender comparison was performed between males and females after adjusting for age using the analysis of covariance. Simple regression analysis was also used to correlate repeated flow estimates at baseline and during hyperemia and to assess the relationship between baseline and hyperemic MBF. ANOVA means table and Fisher's post-hoc test were used to assess the relationship between gender and baseline and hyperemic MBF. ANOVA and Scheffé's posthoc test were used to assess differences in regional MBF of the whole group.

	3 Results

Top Abstract 1 Introduction 2 Methods 3 Results 4 Discussion 5 Conclusions References

 
All subjects tolerated the procedures well except for the common side effects of the adenosine or dipyridamole infusion, but none experienced chest pain or exhibited electrocardiographic changes suggestive of ischemia. For the whole group of 169 subjects, the mean resting heart rate was 63±10 (range 37–99) beats/min, systolic blood pressure 121±15 (range 90–171) mmHg, and diastolic blood pressure 72±10 (range 52–94) mmHg. The mean resting RPP was 7623±1689 (range 4488–14 157) mmHgxbeat/min. Age was linearly associated with systolic (P = 0.0011), diastolic (P = 0.0177), and mean arterial pressure (P = 0.0083) There was also a linear, but nonsignificant trend between age and RPP (P = 0.0900).

At peak adenosine-induced hyperemia, the mean heart rate was 88±15 (range 44–122) beats/min, systolic blood pressure 122±16 (range 86–159) mmHg, diastolic blood pressure 68±10 (range 46–89) mmHg, and mean RPP was 10843±2596 (range 4224–18 178) mmHgxbeat/min. At peak dipyridamole-induced hyperemia, the mean heart rate was 90±15 (range 60–131) beats/min, systolic blood pressure 126±17 (range 85–173) mmHg, diastolic blood pressure 70±10 (range 48–103) mmHg and mean RPP was 11 307±2463 (range 7200–19 030) mmHgxbeat/min.

3.1 Baseline flow
The frequency distributions of global (i.e. mean flow in the whole left ventricle) MBF and MBF_corr are shown in Fig. 1. MBF was 0.985±0.230 ml/min/g (range 0.590–2.050 ml/min/g, coefficient of variation 27%) and MBF_corr 1.330±0.316 ml/min/g (range 0.736–2.428 ml/min/g, coefficient of variation 24%).

View larger version (16K): [in this window] [in a new window] [Download PowerPoint slide]   Fig. 1 Frequency distribution of (left) uncorrected baseline global MBF (coefficient of variation 27.1%) and (right) baseline global MBFcorr (coefficient of variation 24.0%).

 
3.1.1 Effects of age and gender
MBF showed a significant linear association with age (Fig. 2, top), which is partly explained by the trend for an association between age and RPP. The latter is in turn significantly associated with MBF (Fig. 2, middle). In females MBF (1.182±0.251 ml/min/g) and MBF_corr (1.563±0.322 ml/min/g) were significantly higher than MBF (0.930±0.191 ml/min/g) and MBF_corr (1.265±0.284 ml/min/g) in males (P<0.001, for both comparison). The study population was skewed towards a larger number of males and older females. However, MBF in females remained significantly higher than in males (P<0.0001) after adjustment for age. Moreover, neither age nor the interaction between age and gender showed any significance after adjustment for gender (P = 0.81). Regional flows were related to age in a manner similar to that observed for global flows and values were significantly higher in females in all segments (Table 1). After adjustment for age, gender remained significant (P<0.0001). Neither age nor the interaction between age and gender showed any significance after adjustment for gender for each region.

View larger version (20K): [in this window] [in a new window] [Download PowerPoint slide]   Fig. 2 Scatterplot showing the relationship between (top) age and uncorrected baseline global MBF (y = 0.803+0.004x; r = 0.21; P = 0.0086, (middle) RPP and uncorrected baseline global MBF (y = 0.593+5.217x10–5x; r = 0.39; P<0.0001) and (bottom) age and hyperemic global MBF (y = 0.666+0.142x–0.002x2; r = 0.41; P<0.0001). The data points in the bottom panel illustrate the lower hyperemic MBF in subjects older than 55 years. In the few youngest subjects (six of nine), hyperemic MBF was also lower than the mean for the group.

 

View this table: [in this window] [in a new window]   Table 1 Segmental MBF in females and malesa

 
3.1.2 Spatial heterogeneity
The distribution of MBF_corr within each myocardial region in the whole study population is illustrated in Fig. 3. MBF_corr was 1.333±0.329 ml/min/g in the septum, 1.443±0.4113 ml/min/g in the anterior wall, 1.405±0.385 ml/min/g in the lateral wall and 1.232±0.322 ml/min/g in the inferior wall. The overall ANOVA P value for regional MBF_corr was <0.0001, with an F factor of 9.145. Posthoc analysis showed significant differences in MBF among the following segments: inferior vs. anterior (P<0.0001) and inferior vs. lateral (P<0.0001).

View larger version (34K): [in this window] [in a new window] [Download PowerPoint slide]   Fig. 3 Histogram of corrected baseline regional MBF. The coefficient of variation for each segment was: septum, 24.7%; anterior, 28.6%; lateral, 25.3% and inferior 26.1%.

 
The true variability of baseline MBF was assessed by comparing paired estimates of regional baseline MBF within each individual at a single time point. There were significant differences in both uncorrected and corrected estimates of baseline myocardial blood flow among the following regions: anterior vs. inferior (P<0.001); anterior vs. septum (P<0.001); inferior vs. lateral (P<0.001); inferior vs. septum, (P<0.001); and lateral vs. septum (P<0.001), but not between anterior vs. lateral segments. The dispersion among these four regions may be summarized by the average coefficient of variation, which was 13±8% for both uncorrected and corrected estimates of baseline flow.

3.1.3 Temporal heterogeneity
In the subgroup of 21 individuals undergoing repeated assessment of MBF, there was no significant difference between the coefficients of variation (19.1627 vs. 19.1913; P = NS) for the first and the second baseline MBF_corr. There was a good correlation between the two baseline MBF_corr measurements (r = 0.756; P<0.0001). Moreover, for each region, the coefficients of variation between the first and second regional baseline MBF_corr were not significantly different.

3.2 Hyperemic flow
Global hyperemic MBF was 3.542±1.010 ml/min/g (range 1.110–5.990 ml/min/g, coefficient of variation 29%).

3.2.1 Comparison between adenosine- and dipyridamole-induced hyperemia
Females received only dipyridamole for pharmacologic vasodilation while males received either dipyridamole or adenosine for reasons stated previously (see Methods). Therefore, the comparison of adenosine- vs. dipyridamole-induced hyperemia was performed only in males. Hyperemic MBF response to adenosine (mean 3.766±0.854, range 1.851–5.990) was significantly (P = 0.0114) higher than that to dipyridamole (mean 3.107±1.120, range 1.100–5.270) at these doses of stressors.

3.2.2 Effects of age and gender
Gender differences in hyperemic MBF were tested only for dipyridamole-induced hyperemia. The gender difference observed for baseline MBF was not present for hyperemic MBF. There also appears to be a quadratic relation between age and hyperemic MBF (Fig. 2, bottom) with flows lower than the group's mean in subjects older than 55 years and in few youngest subjects (six of nine).

3.2.3 Spatial heterogeneity
Similarly to baseline, regional hyperemic MBF showed a considerable range of responses: septum, 0.915–7.305; anterior, 1.150–8.134; lateral, 1.050–7.153; and inferior, 0.750–6.980 ml/min/g. The histogram in Fig. 4. top illustrates the broad range of distribution of regional hyperemic flow in the whole population. However, there were no statistically significant differences (ANOVA) in hyperemic MBF among the four myocardial regions. The true spatial heterogeneity for each individual at a single time point was shown by the statistically significant difference in MBF between the inferior wall and all the other regions (P<0.001 in each case). The dispersion was slightly greater than for baseline MBF with a coefficient of variation of 17±10%. To test whether the hyperemic response was related to baseline MBF, we compared baseline and hyperemic MBF in the same regions. Fig. 4, bottom illustrates the lack of correlation between baseline and hyperemic MBF in each region (r = 0.23; P = NS). In other words, regions with a higher baseline flow were not more likely to have higher hyperemic response than regions with a lower baseline flow.

View larger version (24K): [in this window] [in a new window] [Download PowerPoint slide]   Fig. 4 Histogram showing the distribution of hyperemic regional MBF in the population (top). The coefficient of variation was 34.1%. Scatterplot (bottom) comparing baseline MBF hyperemic MBF for the same region demonstrates a lack of correlation between baseline and maximal flow patterns (r = 0.23; P = NS).

 
3.2.4 Temporal heterogeneity
In the 21 individuals undergoing repeated assessment of MBF, there was no significant difference between the coefficients of variation (23.6534 vs. 25.2366; P = NS) for the first and the second hyperemic MBF. Likewise there were no regional differences in the coefficients of variation for hyperemic flows.

3.3 Coronary vasodilator reserve
Global CVR with adenosine and dipyridamole showed a wide range of responses from 1.360 to 8.130 (mean 3.753±1.240) for uncorrected and from 1.020 to 6.300 (mean 2.794±0.947) for corrected (Fig. 5). The relationship between age and CVR follows a similar pattern observed for age and hyperemic MBF (Fig. 2, bottom). There was also a wide distribution of regional CVR_corr. There was no significant difference in either uncorrected or corrected CVR among different regions.

View larger version (17K): [in this window] [in a new window] [Download PowerPoint slide]   Fig. 5 Histogram showing the distribution of uncorrected (left) and corrected (right) CVR. The coefficient of variation was 33.0 and 33.9%, respectively.

 

	4 Discussion

Top Abstract 1 Introduction 2 Methods 3 Results 4 Discussion 5 Conclusions References

 
In the present study, we have investigated the limits of MBF in a large population of healthy males and females over a broad range of ages. We specifically selected human subjects with a low likelihood for coronary artery disease [18]. The results can be summarized as follows. (1) In this population, baseline and hyperemic MBF are heterogeneous both within and between individuals. Baseline and hyperemic MBF exhibit a similar degree of spatial heterogeneity which appears to be temporally stable. (2) Baseline, but not hyperemic, MBF is significantly higher in females than in males. (3) There is a significant linear association between age and baseline MBF that is in part related to changes in external cardiac workload with age. (4) Hyperemic MBF declines over 65 years of age. (5) At the doses employed in the present study, adenosine-induced hyperemic MBF is significantly higher than dipyridamole-induced hyperemic MBF.

Our results are in agreement with previous animal and human studies [7,11–13,26–29] that have provided evidence for significant heterogeneity of global and regional baseline MBF. A number of considerations suggest that this heterogeneity reflects a true biologic phenomenon. First, there is spatial heterogeneity of MBF within each individual to support the overall variability of global MBF. Second, the degree of spatial heterogeneity exhibited in this study is similar to that found in animal [6,8,10–12,30,31] and smaller human [13,26,27] studies using different methods with different spatial resolution to estimate MBF, suggesting that our observation is not a methodological artifact. Third, this spatial heterogeneity exhibits remarkable temporal stability. Fourth, the temporal variability of PET is small as demonstrated by the high repeatability of MBF measured 20 min apart in the same subjects [17].

Both temporal and spatial heterogeneity of MBF have been described in animals [10], however, the underlying physiologic mechanism for the heterogeneity of baseline MBF in humans remains ill defined. We have already demonstrated [17] that PET estimates of MBF are reproducible over time. Small temporal fluctuations in baseline MBF may be attributed to ‘twinkling’ of capillary flows [30] and/or time-dependent changes in regional metabolic requirements coupled to local autoregulatory changes in blood flow [6,8,32]. In addition, the spatial heterogeneity of MBF may be also attributed to the fractal nature of regional flow distribution [33,34] and different neural regulatory modulation in different regions and layers of the left ventricle [10,32]. Differences in transmural MBF distribution across the left ventricle [35–39] may also contribute to the spatial heterogeneity although their magnitude is smaller than the overall heterogeneity [32].

As demonstrated by our results, the inter-individual variability of hyperemic MBF is even greater than that observed for baseline MBF. Both age and the type of vasodilator used determine the degree of hyperemia achieved and thus are sources of variability. Therefore, these factors need to be considered when comparisons of different populations are performed. On the other hand, the intrinsic variability due to spatial heterogeneity within the same hearts was found to be limited to a consistently lower flow in the inferior wall.

In conscious primates, the heterogeneity of MBF before coronary occlusion can explain the variability in myocardial salvage following reperfusion. The presence of higher precoronary occlusion resting MBF may predict the propensity for infarction in that region [12]. In our investigation of normal humans, baseline MBF did not predict hyperemic MBF in the same region. The result is a wide range of regional CVR, which has important clinical implications. Measurements of regional CVR of less than 2.5 are often interpreted as impaired vasodilator capacity. However, in our population of normal volunteers, many left ventricular segments have a CVR, both uncorrected and RPP-corrected, of less than 2.5. This distribution of both MBF and CVR must be recognized before defining these parameters as abnormal. These findings may also explain, at least in part, the patchy distribution of myocardial injury within a given region and suggests that there may be regions operating near maximal capacity in the baseline state, becoming more susceptible to injury when demand exceeds supply [12].

4.1 Aging, myocardial blood flow and coronary vasodilator reserve
The influence of age on baseline MBF has been previously investigated by our and other groups with PET [13,28,40]. The results of the present study confirm that baseline MBF increases linearly with age with greater heterogeneity of baseline MBF in the oldest individuals (Fig. 2, top). Furthermore, the linear association between age and baseline MBF seems to be explained in part by the linear association between age and RPP.

In agreement with previous studies [26,28,41–43] we find that hyperemic MBF declines with increasing age (Fig. 2, bottom). Therefore, in subjects older than 65 years, the combination of the increase in baseline and reduction in hyperemic MBF leads to an even larger decrease in CVR. These changes are likely to results from the combination of a number of mechanical and neurohumoral factors associated with aging including increased arterial impedance, thickening of left ventricular myocardium, reduced lusitropism, reduced catecholamine-responsiveness, endothelial dysfunction and deficient neuroendocrine regulation [26,44–46]. We believe that this decrease in CVR is a true phenomenon since other investigators, using different techniques, have found similar results. With regard to the apparent reduction in hyperemic MBF in the youngest individuals (Fig. 2C), it is worth noting that because of the limitations due to ethical issues, only a small number of subjects were studied. Therefore, we cannot rule out a sampling bias, although the fit of the curve is statistically significant. Finally, there are no data on whether aging modulates the pharmacological effects of dipyridamole and adenosine, but it is conceivable that peak vasodilation could occur at different times in younger than in older individuals.

4.2 Gender, myocardial blood flow and coronary vasodilator reserve
We and others have previously reported gender differences in baseline MBF [28,47,48]. The present investigation in a larger population confirms that baseline MBF is higher in females even after RPP correction. Although in the whole study population the mean age of females was significantly higher than that of males, after adjustment for age, the influence of gender on baseline MBF remained significant. This difference can be explained, at least in part, by the well known effects of estrogens on vascular tone in female subjects with coronary artery disease [49].

Using dipyridamole as vasodilator, we found higher hyperemic flow in females than in males although this difference fell short of statistical significance. Similar findings were noted in previous studies using the same protocol of dipyridamole infusion in syndrome X patients, and using either adenosine or dipyridamole infusion in normal subjects [28,47]. While females in our study had slightly higher hyperemic flow than males, their CVR was overall lower than in males due to the females' higher baseline flow. The latter point should be taken into account when assessing CVR in females.

4.3 Hyperemic response and stressor
In our group of normal men, adenosine at a dose of 140 µg/kg/min appears to induce a slightly greater hyperemia than dipyridamole at a dose of 0.56 mg/kg although there was considerable overlap of hyperemic response between the two agents. In a previous study with PET, MBF hyperemic response was measured twice with both adenosine and dipyridamole in 20 normal men and no significant difference in the level of hyperemia was detectable between the two agents [40]. This disagreement could be due to a variance of inter-individual responsiveness to inhibition of phosphodiesterase and/or density of A₂ receptors. Therefore it can be assumed that the two drugs are equipotent in the same subject, but direct stimulation of A₂ receptors with adenosine is more likely to induce in the majority of cases maximal vasodilatation.

4.4 Limitations of the study
The present study has several potential limitations. (1) Although this group of subjects was carefully screened for coronary artery disease and was at low-risk by history, physical examination, and laboratory results, asymptomatic coronary artery disease may still exist, particularly in the older adults. A coronary angiogram would provide definitive data, but ethical considerations restrain invasive diagnostic in healthy subjects. CVR assessment, however, revealed no evidence of regional deficits in any of the subjects, making the presence of hemodynamically significant coronary stenoses unlikely. Similarly, we cannot completely rule out age-related changes in ventricular function and morphology, which may result in an abnormal flow reserve, although there were no electrocardiographic abnormalities suggesting underlying pathology. Along these lines, it is beyond the scope of this study to determine whether the lack of response to coronary vasodilator stimuli in the absence of coronary artery disease is a true biological phenomenon in some individuals. Since there are reports that the standard dose of dipyridamole (0.56 mg/kg) does not consistently produce maximal vasodilatory effect in all individuals [42], it is conceivable that there are nonresponders, perhaps as a result of operating near maximal capacity at baseline [12], differences in dietary influences [50], or variations in the pharmacological effects of these vasodilator stimuli. Although patients were instructed not to consume caffeine-containing foods and beverages prior to the study, we did not measure caffeine levels in all patients, leaving a possibility of a blunted vasodilator effect due to the presence of xanthines. (2) Our population was skewed towards fewer and older females. Nevertheless, we were able to perform meaningful statistical analyses on this distribution of females and males. Unfortunately, we did not have the estrogen status of the female subjects in this study and therefore could not provide further analyses on the effects of estrogen on MBF and delineate whether estrogen is the mechanism of higher flow in women than in men. (3) The resolution of the scanner in this study does not permit evaluation of smaller regions of interest, which may provide a closer insight into the mechanisms underlying the observed flow variability. In particular, it was not within the scope of this study to differentiate as to whether the observed reduction in flow to the inferior wall compared to other regions is a true biological phenomenon or a methodological artifact. However, a lower basal average peak velocity measured by Doppler-tipped guide wire has previously been observed [51], suggesting the possibility that the lower inferior baseline flow may be a true biological phenomenon. Furthermore, since baseline flow is closely coupled to myocardial workload and oxygen consumption, it could be hypothesized that these differences in regional blood flow are the consequence of parallel differences in workload and oxygen consumption. Unfortunately, in our study, we did not assess regional workload nor oxygen consumption, and therefore we cannot prove whether this hypothesis is correct. A number of methodological reasons could also account, at least in part, for the observed regional changes. Most importantly, changes in regional wall thickness could result in different partial volume effects and count recovery. However, since our data are corrected for partial volume, this does not seem to be the reason. Finally, different amounts of spillover from neighboring organs with high activity such as liver or spleen may have a more significant impact on the inferior wall.

	5 Conclusions

Top Abstract 1 Introduction 2 Methods 3 Results 4 Discussion 5 Conclusions References

 
The results of the present investigation confirm and extend previous findings on the variability of baseline and hyperemic MBF in humans. Our results demonstrate that a number of factors including age, gender, cardiac workload and type of vasodilator drug must be taken into account when considering the limits of distribution of MBF in normal human subjects. These data have important implications for the interpretation of myocardial perfusion studies in patients and the understanding of the pathophysiology of hibernating myocardium.

Time for primary review 28 days.

	Acknowledgements

 
This work was presented in part at the American Heart Association 72nd Scientific Sessions, Circulation 100: 456, 1999. We are indebted to Dr. Raymond J. Gibbons for his constructive criticism. We gratefully acknowledge the technical assistance of the radiographers of the MRC Cyclotron Unit, Hammersmith Hospital. Dr. Chareonthaitawee was supported by a grant from the Mayo Clinic and Foundation. Dr. Kaufmann was funded by a grant from the Swiss National Science Foundation, SCORE B 32-55002.98.

	References

Top Abstract 1 Introduction 2 Methods 3 Results 4 Discussion 5 Conclusions References

 

1. Camici P.G, Rimoldi O. Resting myocardial blood flow in patients with hibernating myocardium quantified by positron emission tomography. Basic Res Cardiol (1997) 92:6–8.[Web of Science][Medline]
2. Gerber B.L, Vanoverschelde J.L, Bol A, et al. Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation. Circulation (1996) 94:651–659.[Abstract/Free Full Text]
3. Marinho N, Keogh B.E, Costa D.C, et al. Pathophysiology of chronic left ventricular dysfunction: new insights from the measurement of absolute myocardial blood flow and glucose utilization. Circulation (1996) 93:737–744.[Abstract/Free Full Text]
4. Vanoverschelde J-L, Wijns W, Depre C, et al. Mechanisms of chronic regional postischemic dysfunction in humans: new insights from the study of non-infarcted collateral-dependent myocardium. Circulation (1993) 1993(87):1513–1523.
5. Rahimtoola S.H. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation (1985) 72(Suppl_V):123–135.
6. Franzen D, Conway R.S, Zhang H, et al. Spatial heterogeneity of local blood flow and metabolite content in dog hearts. Am J Physiol (1988) 254:H344–H353.[Web of Science][Medline]
7. Camici P.G, Gropler R.J, Jones T, et al. The impact of myocardial blood flow quantitation with PET on the understanding of cardiac diseases. Eur. Heart J (1996) 17:25–34.[Free Full Text]
8. King R.B, Bassingthwaighte J.B, Hales J.R.S, et al. Stability of heterogeneity of myocardial blood flow in normal awake baboons. Circ Res (1985) 57:285–295.[Abstract/Free Full Text]
9. Kirk E.S, Honig C.R. Nonuniform distribution of blood flow and gradients of oxygen tension within the heart. Am J Physiol (1964) 207:661–668.[Abstract/Free Full Text]
10. Marcus M.L, Kerber R.E, Ehrhardt J.E, et al. Spatial and temporal heterogeneity of left ventricular perfusion in awake dogs. Am Heart J (1977) 94:748–754.[CrossRef][Web of Science][Medline]
11. Austin R.E Jr., Aldea G.S, Coggins D.L, et al. Profound spatial heterogeneity of coronary reserve: discordance between patterns of resting and maximal myocardial blood flow. Circ Res (1990) 67:319–331.[Abstract/Free Full Text]
12. Ghaleh B, Shen Y.T, Vatner S.F. Spatial heterogeneity of myocardial blood flow presages salvage vs. necrosis with coronary artery reperfusion in conscious baboons. Circulation (1996) 94:2210–2215.[Abstract/Free Full Text]
13. Czernin J, Müller P, Chan S, et al. Influence of age and hemodynamics on myocardial blood flow and flow reserve. Circulation (1993) 88:62–69.[Abstract/Free Full Text]
14. Uren N.G, Melin J.A, De Bruyne B, et al. Relation between myocardial blood flow and the severity of coronary artery stenosis. New Eng J Med (1994) 330:1782–1788.[Abstract/Free Full Text]
15. Marcus M.L, Wilson R.F. Methods of measurement of myocardial blood flow in patients: a critical review. Circulation (1987) 37:636–639.
16. Phelps M.E, Maziotta J.C, Schelbert H.R. Positron emission tomography and autoradiography: principles and applications for the brain and the heart. (1986) New York: Raven Press.
17. Kaufmann P.A, Gnecchi-Ruscone T, Yap J.T, et al. Assessment of the reproducibility of baseline and hyperemic myocardial blood flow measurements with oxygen-15 labeled water and PET. J Nucl Med (1999) 40:1848–1856.[Abstract/Free Full Text]
18. Diamond G.A, Forrester J. Analysis of probability as an aid in the clinical diagnosis of coronary artery disease. New Eng J Med (1979) 300:1350–1358.[Abstract]
19. Radvan J, Marwick T.H, Williams M.J, et al. Evaluation of the extent and timing of coronary hyperemic response to dipyridamole: a study with transesophageal echocardiography and positron emission tomography with oxygen 15 water. J Am Soc Echocardiogr (1995) 8:864–873.[CrossRef][Medline]
20. Spinks T.J, Jones T, Gilardi M.C, et al. Physical performance of the latest generation of commercial positron scanner. IEEE Trans Nucl Sci (1988) 35:721–725.[CrossRef][Web of Science]
21. Hermansen F, Lammertsma A.A. Linear dimension reduction of sequences of medical images: I. optimal inner products. Phys Med Biol (1995) 40:1469–1481.
22. Hermansen F, Bloomfield P.M, Ashburner J, et al. Linear dimension reduction of sequences of medical images: II direct sum decomposition. Phys Med Biol (1995) 40:1921–1941.[CrossRef][Web of Science][Medline]
23. Hermansen F, Rosen S.D, Fath-Ordoubadi F, et al. Measurement of myocardial blood flow with oxygen-15 labelled water: comparison of different administration protocols. Eur J Nucl Med (1998) 25:751–759.[CrossRef][Web of Science][Medline]
24. Araujo L.I, Lammertsma A.A, Rhodes C.G, et al. Noninvasive quantification of regional myocardial blood flow in coronary artery disease with oxygen-15-labeled carbon dioxide inhalation and positron emission tomography. Circulation (1991) 83:875–885.[Abstract/Free Full Text]
25. Sokal R.R, Rohlf F.J. Biometry. (1969) New York: W.H. Freeman.
26. Senneff M.J, Geltman E.M, Bergmann S.R, et al. Noninvasive delineation of the effects of moderate aging on myocardial perfusion. J Nucl Med (1991) 32:2037–2042.[Abstract/Free Full Text]
27. Bergmann S.R, Herrero P, Markham J, et al. Noninvasive quantitation of myocardial blood flow in human subjects with oxygen-15-labeled water and positron emission tomography. J Am Coll Cardiol (1989) 14:639–652.[Abstract]
28. Uren N.G, Camici P.G, Melin J.A, et al. Effect of aging on myocardial perfusion reserve. J Nuc Med (1995) 36(11):2032–2036.[Abstract/Free Full Text]
29. Camici P.G, Wijns W, Borgers M, et al. Pathophysiological mechanisms of chronic reversible left ventricular dysfuncion due to coronary artery disease (hibernating myocardium). Circulation (1997) 96:3205–3214.[Free Full Text]
30. Yipintsoi T, Dobbs W.A Jr., Scanlon P.D, et al. Regional distribution of diffusible tracers and carbonized microspheres in the left ventricle of isolated dog hearts. Circ Res (1973) 33:573–587.[Abstract/Free Full Text]
31. Wolpers H.G, Geppert V, Hoeft A, et al. Estimation of myocardial blood flow heterogeneity by transorgan helium transport functions. Pfluegers Arch (1984) 401:217–222.[CrossRef][Web of Science][Medline]
32. Deussen A. Blood flow heterogeneity in the heart. Basic Res Cardiol (1998) 93:430–438.[CrossRef][Web of Science][Medline]
33. Bassingthwaighte J.B, King R.B, Roger S.A. Fractal nature of regional myocardial blood flow heterogeneity. Circ Res (1989) 65:578–590.[Abstract/Free Full Text]
34. Van Beek J.H.G.M, Roger S.A, Bassingwaigthe J.B. Regional myocardial flow heterogeneity explained with fractal netwoks. Am J Physiol (1989) 257:H1670–H1680.[Web of Science][Medline]
35. Reneman R.S, Verheyen W, van Greven W, et al. The importance of size and diameter distribution of the microspheres for accurate determination of regional myocardial blood flow (MBF). Bibl Anat (1977) 15:30–34.[Medline]
36. Prinzen F.W, van der Vusse G.J, Reneman R.S. Blood flow distribution in the left ventricular free wall in open-chest dogs. Basic Res Cardiol (1981) 76:431–437.[CrossRef][Web of Science][Medline]
37. Ball R.M, Bache R.J, Cobb F.R, et al. Regional myocardial blood flow during graded treadmill exercise in the dog. J Clin Invest (1975) 55:43–49.[Web of Science][Medline]
38. Cobb F.R, Bache R.J, Greenfield J.C Jr. Regional myocardial blood flow in awake dogs. J Clin Invest (1974) 53:1618–1625.[Web of Science][Medline]
39. Prokop E.K, Strauss H.W, Shaw J, et al. Comparison of regional myocardial perfusion determined by ionic potassium-43 to that determined by microspheres. Circulation (1974) 50:978–984.[Abstract/Free Full Text]
40. Chan S.Y, Brunken R.C, Czernin J, et al. Comparison of maximal myocardial blood flow during adenosine infusion with that of intravenous dipyridamole in normal men. J Am Coll Cardiol (1992) 20:979–985.[Abstract]
41. Verani M.S, Mahmarian J.J, Hixon J.B, et al. Diagnosis of coronary artery disease by controlled vasodilation with adenosine and thallium-201 scintigraphy in patients unable to exercise. Circulation (1990) 82:80–87.[Abstract/Free Full Text]
42. Rossen J.D, Simonetti I, Marcus M.L, et al. Coronary dilation with standard dose dipyridamole and dipyridamole combined with handgrip. Circulation (1989) 79:566–572.[Abstract/Free Full Text]
43. Wilson R.F, Wyche K, Christensen B.V, et al. Effects of adenosine on human coronary arterial circulation. Circulation (1990) 82:1595–1606.[Abstract/Free Full Text]
44. Lüscher T.F, Noll G. Endothelium-dependent vasomotion in aging, hypertension and heart failure. Circulation (1993) 87(Suppl VII):97–103.
45. Egashira K, Inou T, Hirooka Y, et al. Effects of age on endothelium-dependent vasodilation of resistance coronary arteries by acetylcholine in humans. Circulation (1993) 88:77–81.[Abstract/Free Full Text]
46. Lakatta E.G. Deficient neuroendocrine regulation of the cardiovascular system with advancing age in healthy humans. Circulation (1993) 87:631–636.[Free Full Text]
47. Rosen S.D, Uren N.G, Kaski J.-C, et al. Coronary vasodilator reserve, pain perception, and sex in patients with syndrome X. Circulation (1994) 90:50–60.[Abstract/Free Full Text]
48. Duvernoy C.S, Meyer C, Seifert-Klauss V, et al. Gender differences in myocardial blood flow dynamics: lipid profile and hemodynamic effects. J Am Coll Cardiol (1999) 33:463–470.[Abstract/Free Full Text]
49. Collins P, Rosano G.M.C, Sarrel P, et al. 17β-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation (1995) 92(1):24–30.[Abstract/Free Full Text]
50. Smits P, Thien T.H, van't Laar A. Circulatory effects of coffee in relation to the pharmacokinetics of caffeine. Am J Cardiol (1985) 56:958–963.[CrossRef][Web of Science][Medline]
51. Kern M.J, Bach R.G, Mechem C.J, et al. Variations in normal coronary vasodilatory reserve stratified by artery, gender, heart transplantation and coronary artery disease. J Am Coll Cardiol (1996) 28:1154–1160.[Abstract]

CiteULike    Connotea    Del.icio.us    What's this?

This article has been cited by other articles:

				P. G. Camici and O. E. Rimoldi The Clinical Value of Myocardial Blood Flow Measurement J. Nucl. Med., July 1, 2009; 50(7): 1076 - 1087. [Abstract] [Full Text] [PDF]

				D. C. Lee and N. P. Johnson Quantification of Absolute Myocardial Blood Flow by Magnetic Resonance Perfusion Imaging J. Am. Coll. Cardiol. Img., June 1, 2009; 2(6): 761 - 770. [Abstract] [Full Text] [PDF]

				A. R. Pries and T. W. Secomb Origins of heterogeneity in tissue perfusion and metabolism Cardiovasc Res, February 1, 2009; 81(2): 328 - 335. [Abstract] [Full Text] [PDF]

				O. Manabe, K. Yoshinaga, C. Katoh, M. Naya, R. A. deKemp, and N. Tamaki Repeatability of Rest and Hyperemic Myocardial Blood Flow Measurements with 82Rb Dynamic PET J. Nucl. Med., January 1, 2009; 50(1): 68 - 71. [Abstract] [Full Text] [PDF]

				F. Crea, P. G. Camici, R. De Caterina, and G. A. Lanza CHAPTER 17 Chronic Ischaemic Heart Disease ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF]

				M. R. Vesely and V. Dilsizian Nuclear Cardiac Stress Testing in the Era of Molecular Medicine J. Nucl. Med., March 1, 2008; 49(3): 399 - 413. [Abstract] [Full Text] [PDF]

				K. M. Marques, P. Knaapen, R. Boellaard, N. Westerhof, A. A. Lammertsma, C. A. Visser, and F. C. Visser Hyperaemic microvascular resistance is not increased in viable myocardium after chronic myocardial infarction Eur. Heart J., October 1, 2007; 28(19): 2320 - 2325. [Abstract] [Full Text] [PDF]

				O. I I Soliman, P. Knaapen, M. L Geleijnse, P. A Dijkmans, A. M Anwar, A. Nemes, M. Michels, W. B Vletter, A. A Lammertsma, and F. J ten Cate Assessment of intravascular and extravascular mechanisms of myocardial perfusion abnormalities in obstructive hypertrophic cardiomyopathy by myocardial contrast echocardiography Heart, October 1, 2007; 93(10): 1204 - 1212. [Abstract] [Full Text] [PDF]

				P. A. Kaufmann, O. E. Rimoldi, T. Gnecchi-Ruscone, T. F. Luscher, and P. G. Camici Systemic nitric oxide synthase inhibition improves coronary flow reserve to adenosine in patients with significant stenoses Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2178 - H2182. [Abstract] [Full Text] [PDF]

				J. R. Duran III, G. Taffet, P. G. Camici, and F. Crea Coronary Microvascular Dysfunction N. Engl. J. Med., May 31, 2007; 356(22): 2324 - 2325. [Full Text] [PDF]

				J. J. Piek Beyond Epicardial Reperfusion N. Engl. J. Med., May 3, 2007; 356(18): 1880 - 1882. [Full Text] [PDF]

				R Vogel, A Indermuhle, and C Seiler Determination of the absolute perfusion threshold preventing myocardial ischaemia in humans Heart, January 1, 2007; 93(1): 115 - 116. [Full Text] [PDF]

				A. N. Mazzadi, X. Andre-Fouet, N. Costes, P. Croisille, D. Revel, and M. F. Janier Mechanisms leading to reversible mechanical dysfunction in severe CAD: alternatives to myocardial stunning Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2570 - H2582. [Abstract] [Full Text] [PDF]

				M. J. Kern, A. Lerman, J.-W. Bech, B. De Bruyne, E. Eeckhout, W. F. Fearon, S. T. Higano, M. J. Lim, M. Meuwissen, J. J. Piek, et al. Physiological Assessment of Coronary Artery Disease in the Cardiac Catheterization Laboratory: A Scientific Statement From the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology Circulation, September 19, 2006; 114(12): 1321 - 1341. [Abstract] [Full Text] [PDF]

				R Jagathesan, E Barnes, S D Rosen, R Foale, and P G Camici Dobutamine-induced hyperaemia inversely correlates with coronary artery stenosis severity and highlights dissociation between myocardial blood flow and oxygen consumption Heart, September 1, 2006; 92(9): 1230 - 1237. [Abstract] [Full Text] [PDF]

				P. Chareonthaitawee, S. D. Christenson, J. L. Anderson, B. J. Kemp, D. O. Hodge, E. L. Ritman, and R. J. Gibbons Reproducibility of Measurements of Regional Myocardial Blood Flow in a Model of Coronary Artery Disease: Comparison of H215O and 13NH3 PET Techniques J. Nucl. Med., July 1, 2006; 47(7): 1193 - 1201. [Abstract] [Full Text] [PDF]

				R. Vogel, R. Zbinden, A. Indermuhle, S. Windecker, B. Meier, and C. Seiler Collateral-flow measurements in humans by myocardial contrast echocardiography: validation of coronary pressure-derived collateral-flow assessment Eur. Heart J., January 2, 2006; 27(2): 157 - 165. [Abstract] [Full Text] [PDF]

				R. Vogel, A. Indermuhle, J. Reinhardt, P. Meier, P. T. Siegrist, M. Namdar, P. A. Kaufmann, and C. Seiler The quantification of absolute myocardial perfusion in humans by contrast echocardiography: Algorithm and validation J. Am. Coll. Cardiol., March 1, 2005; 45(5): 754 - 762. [Abstract] [Full Text] [PDF]

				R. Jagathesan, P. A. Kaufmann, S. D. Rosen, O. E. Rimoldi, F. Turkeimer, R. Foale, and P. G. Camici Assessment of the Long-Term Reproducibility of Baseline and Dobutamine-Induced Myocardial Blood Flow in Patients with Stable Coronary Artery Disease J. Nucl. Med., February 1, 2005; 46(2): 212 - 219. [Abstract] [Full Text] [PDF]

				P. A. Kaufmann and P. G. Camici Myocardial Blood Flow Measurement by PET: Technical Aspects and Clinical Applications J. Nucl. Med., January 1, 2005; 46(1): 75 - 88. [Full Text] [PDF]

				H. Lu, C. Chen, and C. Klaassen TISSUE DISTRIBUTION OF CONCENTRATIVE AND EQUILIBRATIVE NUCLEOSIDE TRANSPORTERS IN MALE AND FEMALE RATS AND MICE Drug Metab. Dispos., December 1, 2004; 32(12): 1455 - 1461. [Abstract] [Full Text] [PDF]

				P. Knaapen, L. M.C. van Campen, C. C. de Cock, M. J.W. Gotte, C. A. Visser, A. A. Lammertsma, and F. C. Visser Effects of Cardiac Resynchronization Therapy on Myocardial Perfusion Reserve Circulation, August 10, 2004; 110(6): 646 - 651. [Abstract] [Full Text] [PDF]

				M. Pitt, D. Dutka, D. Pagano, P. Camici, and R. Bonser The natural history of myocardium awaiting revascularisation in patients with impaired left ventricular function Eur. Heart J., March 2, 2004; 25(6): 500 - 507. [Abstract] [Full Text] [PDF]

				B. Nowak, C. Stellbrink, W. M. Schaefer, A. M. Sinha, O. A. Breithardt, H.-J. Kaiser, P. Reinartz, P. Hanrath, and U. Buell Comparison of Regional Myocardial Blood Flow and Perfusion in Dilated Cardiomyopathy and Left Bundle Branch Block: Role of Wall Thickening J. Nucl. Med., March 1, 2004; 45(3): 414 - 418. [Abstract] [Full Text]

				S. A. J. Chamuleau, M. Siebes, M. Meuwissen, K. T. Koch, J. A. E. Spaan, and J. J. Piek Association between coronary lesion severity and distal microvascular resistance in patients with coronary artery disease Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H2194 - H2200. [Abstract] [Full Text] [PDF]

				O. M. Muehling, N. M. Wilke, P. Panse, M. Jerosch-Herold, B. V. Wilson, R. F. Wilson, and L. W. Miller Reduced myocardial perfusion reserve and transmural perfusiongradient in heart transplant arteriopathyassessed by magnetic resonance imaging J. Am. Coll. Cardiol., September 17, 2003; 42(6): 1054 - 1060. [Abstract] [Full Text] [PDF]

				C. A. Wyss, P. Koepfli, G. Fretz, M. Seebauer, C. Schirlo, and P. A. Kaufmann Influence of Altitude Exposure on Coronary Flow Reserve Circulation, September 9, 2003; 108(10): 1202 - 1207. [Abstract] [Full Text] [PDF]

				K. Rajappan, O. E. Rimoldi, P. G. Camici, N. G. Bellenger, D. J. Pennell, and D. J. Sheridan Functional Changes in Coronary Microcirculation After Valve Replacement in Patients With Aortic Stenosis Circulation, July 1, 2003; 107(25): 3170 - 3175. [Abstract] [Full Text] [PDF]

				G. C. Hughes, M. J. Post, M. Simons, and B. H. Annex Translational Physiology: Porcine models of human coronary artery disease: implications for preclinical trials of therapeutic angiogenesis J Appl Physiol, May 1, 2003; 94(5): 1689 - 1701. [Abstract] [Full Text] [PDF]

				C. A. Wyss, P. Koepfli, K. Mikolajczyk, C. Burger, G. K. von Schulthess, and P. A. Kaufmann Bicycle Exercise Stress in PET for Assessment of Coronary Flow Reserve: Repeatability and Comparison with Adenosine Stress J. Nucl. Med., February 1, 2003; 44(2): 146 - 154. [Abstract] [Full Text] [PDF]

				P. G Camici and O. E Rimoldi Myocardial blood flow in patients with hibernating myocardium Cardiovasc Res, February 1, 2003; 57(2): 302 - 311. [Abstract] [Full Text] [PDF]

				N. Spyrou, S. D. Rosen, F. Fath-Ordoubadi, R. Jagathesan, R. Foale, J. S. Kooner, and P. G. Camici Myocardial beta-adrenoceptor densityone month after acute myocardial infarctionpredicts left ventricular volumes at six months J. Am. Coll. Cardiol., October 2, 2002; 40(7): 1216 - 1224. [Abstract] [Full Text] [PDF]

				M. Siebes, S. A. J. Chamuleau, M. Meuwissen, J. J. Piek, and J. A. E. Spaan Influence of hemodynamic conditions on fractional flow reserve: parametric analysis of underlying model Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1462 - H1470. [Abstract] [Full Text] [PDF]

				R. Jenni, C. A. Wyss, E. N. Oechslin, and P. A. Kaufmann Isolated ventricular noncompaction is associated with coronary microcirculatory dysfunction J. Am. Coll. Cardiol., February 6, 2002; 39(3): 450 - 454. [Abstract] [Full Text] [PDF]

				K. Rajappan, O. E. Rimoldi, D. P. Dutka, B. Ariff, D. J. Pennell, D. J. Sheridan, and P. G. Camici Mechanisms of Coronary Microcirculatory Dysfunction in Patients With Aortic Stenosis and Angiographically Normal Coronary Arteries Circulation, January 29, 2002; 105(4): 470 - 476. [Abstract] [Full Text] [PDF]

This Article Abstract FREE Full Text (PDF) E-letters: Submit a response Alert me when this article is cited Alert me when E-letters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to citation manager Request Permissions Disclaimer Google Scholar Articles by Chareonthaitawee, P. Articles by Camici, P. G Search for Related Content PubMed PubMed Citation Articles by Chareonthaitawee, P. Articles by Camici, P. G Social Bookmarking          What's this?

Online ISSN 1755-3245 - Print ISSN 0008-6363

Copyright © 2009 European Society of Cardiology

Oxford Journals Oxford University Press

• Site Map
• Privacy Policy
• Frequently Asked Questions

Other Oxford University Press sites: Oxford University Press Oxford Journals China Oxford Journals Japan American National Biography Booksellers' Information Service Children's Fiction and Poetry Children's Reference Corporate & Special Sales Dictionaries Dictionary of National Biography Digital Reference English Language Teaching Higher Education Textbooks Humanities International Education Unit Law Medicine Music Online Products Oxford English Dictionary Reference Rights and Permissions Science School Books Social Sciences Very Short Introductions World's Classics